Although APOE ε4 has been identified as a key genetic risk factor for AD, it is evident that AD is a genetically heterogeneous disorder, necessitating the investigation of additional genetic contributors beyond APOE ε4. This evidence concerns the gene APOE and Alzheimer disease.